Why Work at Indegene

Impact

Innovation

Inspiration

Explore Opportunities

Carlyle, Brighton Park invest $200 million in drug development firm Indegene

Global private equity fund Carlyle and US-based Brighton Park Capital have acquired an undisclosed minority stake in Bengaluru-based drug development services and technology provider Indegene for $200 million (Rs 1,461 crore).

Know more